Tumor necrosis factor alpha—an underestimated risk predictor in patients undergoing transcatheter aortic valve replacement (TAVR)?Moritz Mirna, Michael Lichtenauer, Albert Topf et al.|Journal of Clinical Laboratory Analysis|2021Cited by 6